In the current study, NGS‐based genetic diagnosis 14, 34, 35, 36 was used to identify a novel heterozygous missense mutation of the gene BRCA2: c.7007G>T, p.R2336L, in a Chinese breast cancer family. This evidence concerns the gene BRCA2 and breast cancer.